• There are no suggestions because the search field is empty.

UDI for software: how to mark your MDSW with a UDI?

Author Avatar
Anne-Sophie Grell, RA Manager MD at QbD Group
Regulatory Affairs
Medical Devices
Each individual medical device must have a Unique Device Identifier (UDI) with its carrier (barcode or QR code). But what about medical device software? Read the answer in this article!
UDI for software: how to mark your MDSW with a UDI? | QbD Group
5:30

We recently published a blog post about Unique Device Identifiers (UDI). While this blog post briefly explains what a UDI is and how to implement it on your medical devices, it may still be unclear how it applies to Medical Device Software (MDSW).

Well, the principle remains the same: each individual medical device must have a Unique Device Identifier with its carrier (barcode or QR code).

However, since it is impossible to print a barcode on software, the question remains how to implement the UDI on MDSW. Since this is a complicated question, the Medical Device Coordination Group has created a document with guidelines on UDI assignment to software (MDCG 2018-5).

 

Recap: what is a UDI?

A UDI consists of a Basic UDI-DI and a UDI which comprises the UDI-DI (Device Identifier) and the UDI-PI (Product Identifier).

The basic UDI-DI (BUDI-DI) = the primary identifier of a device model. Assigned at the level of the device unit of use. It is the main access key for device-related information in EUDAMED and is referenced in relevant certificates, the EU Declaration of Conformity (EU DoC), Technical Documentation (TD), and Summary of Safety and Clinical Performances (SSCP).

The UDI-DI is a static number, that is required for each individual product and is specific to a version or model of a device. The UDI-PI identifies the production unit and, if applicable, the packaged devices. It provides information on the lot number, serial number, manufacturing date, expiration date, etc.

UDI for software: how to mark your MDSW with a UDI?

Figure 1 – Example of a UDI

 

A UDI consists of an Automatic Identification and Data Capture (AIDC) part and a Human Readable Interpretation (HRI) part.

  • The AIDC is a technology used to automatically capture data, including bar codes, smart cards, biometrics, and radio-frequency identification (RFID).
  • The HRI is a legible interpretation of the data characters encoded in the UDI. Both the AIDC and HRI should contain the complete UDI information.

As explained in our previous blogpost on UDI, there are 4 designating entities that can assign this:

  • GS1
  • HIBCC
  • ICCBBA
  • IFA

Assigning a UDI to software

Before assigning a UDI to software, check whether your software meets the definition of an MDSW. This is written in Annex VI part C of the Medical Device Regulation and the In-Vitro Diagnostic Regulation.  

A UDI is only required for software that is commercially available on its own and software that constitutes a medical device in itself. See also MDCG 2019-11: Guidance on Qualification and Classification of SW in MDR and IVDR.

 

DI and PI modification

If there is a modification that changes the original performance, the safety or intended use of the software, or the interpretation of the data, a new UDI-DI is needed. Moreover,

  • any change of the basic UDI-DI
  • or a change to the
    • name or trade name,
    • version or model number,
    • critical warnings or contra-indications,
    • or user interface language

also require a new UDI-DI. This way, the traceability and correct identification of the medical device software are guaranteed. 

Minor software revisions require only a new UDI-PI, not a new UDI-DI. Minor software revisions include

  • bug fixes,
  • usability enhancements that are not for safety purposes,
  • security patches
  • or operating efficiency.

These minor revisions have to be identified by a defined manufacturer-specific form of identification.

 

How to implement the UDI on the SW?

There are several ways to implement the UDI in the software, depending on how the software is delivered to the customer.

All the details are explained in Annex VI, Part C, point 6.5.4 of the MDR, and Annex VI, Part C, point 6.2.4 of the IVDR. Below is a small overview:

Physical medium

If the software is delivered on a physical medium, for example a CD or DVD, each packaging level shall have the HRI and AIDC of the complete UDI on it. In the EU, the UDI linked to your system level software should be the same as the one to your packaging level. In the US, a different UDI-DI is allowed for the packaging.

Software with User Interface

If there is an interface, the HRI UDI shall be provided on a readily accessible screen for the user in an easily-readable plain-text format. The UDI can for example be placed in an ‘about’ file or in the start-up screen.

Software without User Interface

If the software doesn’t have a user interface, the UDI shall be transmitted through an application programming interface.

Other rules on the application of a UDI on MDSW

There are two extra rules for the application of a UDI on MDSW. Firstly, for electronic displays, only the HRI is required. AIDC is not required, but it is of course optional.

Secondly, the human-readable UDI should also include the Application Identifiers for the standard used by issuing entities. This is done to assist the user in identifying the UDI and determining which standard is being used to create the UDI.

 

Need help with your UDI for MDSW?

There are several options for putting a UDI on MDSW, depending on whether your software is on a physical medium, and whether or not it has a User Interface. In this blog you learned what those options are, but should you need additional help, please contact the QbD Group.

 

 

Stay ahead in life sciences

Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

Circles-banner-short

Discover more expert content

preview_image
Case study

A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader​

QbD Group streamlines linguistic reviews for a leading pharma client, ensuring compliance and accuracy across 25 EU/EEA languages while meeting stringent regulatory deadlines.
preview_image
Whitepaper

Medical Device Regulation (MDR) Checklist

Implement the Medical Device Regulation (MDR) with ease. Download our checklist of mandatory documents for MDR compliance.
preview_image
Whitepaper

Regulatory Affairs for Pharma and Biotech

In this flyer, you will learn more about the regulatory services QbD Group provides for the pharmaceutical and biotechnology industries.
preview_image
Whitepaper

Clinical Evaluation for Medical Devices under MDR

This whitepaper will guide you through crucial regulatory documents pertaining to the clinical evaluation process of your medical device. Download now!
preview_image
Whitepaper

IVDR extension: what does this mean for you?

In this whitepaper, you will learn the impact of the IVDR transition extension and receive tips and strategies to navigate these regulatory changes.
preview_image
Webinar

Drug-Device Combination Products and Article 117

Explore the regulatory complexities of Drug-Device Combination Products. Learn about Article 117 requirements, Notified Body Opinions, and more.
preview_image
Whitepaper

Mobile health on the rise: exploring the regulatory landscape for reimbursement

This whitepaper will help you navigate the maze of the DTx regulatory environment, highlighting several important countries and regulations.
preview_image
Whitepaper

Clinical investigations under MDR: key insights and practical experiences

This whitepaper covers clinical investigation authorization under MDR, the EU Legal Representative's role, and the MDR's impact on study conduct and post-market surveillance.
preview_image
Case study

CE Mark Renewal for bioXtra Products: A Success Story

Discover how Lifestream Pharma successfully renewed the CE mark for their BioXtra Dry Mouth products under the EU MDR. Learn about the challenges faced, the approach taken for compliance, and the results achieved.
preview_image
Webinar

Technical Documentation Essentials for Medical Device Software

Gain practical insights on crafting MDR-compliant technical documentation for Medical Device Software.
preview_image
Webinar

Getting Started: Overcoming Initial Obstacles in Medical Device Software Development

Watch our webinar on demand and learn about regulatory obstacles, MDR, AI Act, and best practices for medical device software development and market entry.
preview_image
Webinar

Mastering Clinical Performance Studies under IVDR

In the evolving regulatory landscape of IVDs, demonstrating clinical performance is more crucial and challenging than ever. Discover more in this webinar on demand.
preview_image
Whitepaper

Clinical evidence for In Vitro Diagnostics under IVDR

In this whitepaper, we will guide you through the documents required for the demonstration of clinical evidence under the IVDR. Download now.
preview_image
Webinar

Post-Market Surveillance Requirements for Medical Devices and IVDs

Learn about post-market surveillance requirements under MDR and IVDR regulations. Gain insights from industry experts in this on-demand webinar.
preview_image
Whitepaper

The key role of Regulatory Affairs in the pharmaceutical industry: from drug development to commercialization

Discover the key role of Regulatory Affairs in pharma and how Regulatory Affairs teams support product lifecycle management in this whitepaper. Download now.
preview_image
Webinar

3D Printing in the Healthcare World

Explore the challenges and opportunities of 3D printing in healthcare, featuring expert insights on regulations, pitfalls, and efficiency.
preview_image
Webinar

IVDR Extension Explained: Tips & Strategies

Gain valuable insights on the IVDR extension and its impact on IVD manufacturers with our webinar on demand.
preview_image
Whitepaper

Innovations in ATMP: state of the industry in 2024

This whitepaper explores the innovations in ATMP and solutions in detail, with a focus on the current landscape as of April 2024. Download now.
preview_image
Case study

The journey toward IVDR compliance for the LVOne device

QbD Group helped Upfront Diagnostics gain entry into the MD/IVD industry by supporting them on their path to ISO 13485 certification.
preview_image
Case study

Ensuring a smooth MDR transition for Oystershell's medical devices

The landscape of medical device regulations is constantly evolving, making it a challenge for companies to keep up. Our collaboration with Oystershell, which began in July 2023, highlights our expertise in transforming complex challenges into success stories, all with a touch of QbD Clinical magic.
preview_image
Case study

Successful clinical evaluation supports rapid CE marking of Minze Health's Uroflowmeter

QbD Clinical assisted Minze Health, a urology-focused medical devices company, in obtaining CE marking under MDR through clinical evaluation.
preview_image
Webinar

The Medical Device CE Certification Pathway Explained: From Classification to Conformity Assessment by the Notified Body

Learn about the Medical Device CE Certification Pathway, from classification to conformity assessment by a Notified Body. Join our webinar on demand.
preview_image
Case study

Helping Relu to comply with changing regulations

QbD Group supported software company Relu with their expertise to comply with changing regulations.
preview_image
Case study

Quickly bringing a new COVID-19 medical device to market

Obtaining the required government certifications for a medical device is always a challenge. Especially when the COVID clock is ticking.